An Overview of Adalimumab Therapy for Ankylosing Spondylitis
Anna M. Sukhanova,
Mariam A. Gilavian,
Elizaveta V. Melnik
et al.
Abstract:Background:
Ankylosing spondylitis (AS) is a chronic inflammatory disease known
for causing pain, stiffness, and reduced mobility in the axial skeleton. Adalimumab, a tumor necrosis
factor (TNF) inhibitor, has emerged as a promising therapeutic option for AS.
Methods:
This systematic review involved a comprehensive search of randomized controlled
trials related to AS treatment, conducted in major databases such as MEDLINE, Google Scholar,
and PubMed. The search terms encompassed ankylosing spondylitis, adali… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.